Step into a dermatologist’s office and the cosmetic world is your oyster. There are five FDA-approved neuromodulators at your disposal, RF microneedling machines, ablative lasers, chemical peels, and fillers galore. As of this week, doctors are going to have one more tool in their kit: SKINVIVE, which is unlike anything currently on the market. The micro droplet, hyaluronic acid injection, which was just approved by the FDA, is intent on smoothing out the skin and providing hydration, specifically on the cheeks.
“Oftentimes, new fillers are really just competitors for an existing class of fillers. SKINVIVE is actually the first in a new class of fillers, and we haven’t had that happen in a very, very long time,” says Dr. Macrene Alexiades, M.D. Ph.D. PLLC, dermatologist, founder of MACRENE Actives, and SKINVIVE by JUVEDERM clinical trial investigator. “It functions in a novel way that replaces or allows us to have an injectable alternative to what we would historically treat with either skin topicals, peels, or lasers.”
